136 related articles for article (PubMed ID: 15196853)
1. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
3. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
Sun P; Zhang Z; Wan J; Shao M
Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
[TBL] [Abstract][Full Text] [Related]
6. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.
Liu G; Zhou W; Wang LI; Park S; Miller DP; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Lett; 2004 Oct; 214(1):69-79. PubMed ID: 15331175
[TBL] [Abstract][Full Text] [Related]
7. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
[TBL] [Abstract][Full Text] [Related]
9. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.
Ahn J; Gammon MD; Santella RM; Gaudet MM; Britton JA; Teitelbaum SL; Terry MB; Neugut AI; Josephy PD; Ambrosone CB
Cancer Res; 2004 Oct; 64(20):7634-9. PubMed ID: 15492293
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk.
Mohelnikova-Duchonova B; Marsakova L; Vrana D; Holcatova I; Ryska M; Smerhovsky Z; Slamova A; Schejbalova M; Soucek P
Pancreas; 2011 Jan; 40(1):72-8. PubMed ID: 20966810
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer.
Ahn J; Ambrosone CB; Kanetsky PA; Tian C; Lehman TA; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Clin Cancer Res; 2006 Dec; 12(23):7063-70. PubMed ID: 17145829
[TBL] [Abstract][Full Text] [Related]
14. Involvement of NAD(P)H:quinone oxidoreductase 1 and superoxide dismutase polymorphisms in ulcerative colitis.
Kosaka T; Yoshino J; Inui K; Wakabayashi T; Kobayashi T; Watanabe S; Hayashi S; Hirokawa Y; Shiraishi T; Yamamoto T; Tsuji M; Katoh T; Watanabe M
DNA Cell Biol; 2009 Dec; 28(12):625-31. PubMed ID: 19715479
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
Ambrosone CB; Ahn J; Singh KK; Rezaishiraz H; Furberg H; Sweeney C; Coles B; Trovato A
Cancer Res; 2005 Feb; 65(3):1105-11. PubMed ID: 15705913
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
[TBL] [Abstract][Full Text] [Related]
17. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Seibold P; Hall P; Schoof N; Nevanlinna H; Heikkinen T; Benner A; Liu J; Schmezer P; Popanda O; Flesch-Janys D; Chang-Claude J
Breast; 2013 Oct; 22(5):817-23. PubMed ID: 23489758
[TBL] [Abstract][Full Text] [Related]
20. Association between manganese superoxide dismutase polymorphism and risk of lung cancer.
Zejnilovic J; Akev N; Yilmaz H; Isbir T
Cancer Genet Cytogenet; 2009 Feb; 189(1):1-4. PubMed ID: 19167605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
